Tag: KMB

Form-4 Alert, Fresh Options Plays

Nkarta, Inc. NKTX – Form-4 Alert

We took notice of an interesting new IPO this morning in NKTX. Typically we would be more interested in stocks with a long history of data to look at, but in this case a notable name is buying up shares. Mega-laboratory GlaxoSmithKline purchased a noteworthy $15M chunk of NKTX, and the newly issued stock has been in a freefall looking for support.

In our experience, we see a lot of IPO’s that sell off hard directly after their initial offering just like this one. It’s when they establish a firm bottom that the buying opportunity is at its greatest, so we are definitely going to want to keep a close watch over NKTX for that to occur. There may be a solid gain opportunity on the horizon here that we won’t want to miss.

Virgin Galactic Holdings Inc. SPCE

We highlighted some calls in SPCE last week and met with great success, to the tune of several multi-bag gain opportunites. It has continued to run this week, and so far we’ve seen a 39% move in the stock alone from 19.07-23.53.

We are interested in selecting another range of calls to monitor with SPCE faring so well, so we’re going to place the SPCE $25.50-26.50 Calls on watch for the remainder of the week.

GeoVax Labs, Inc. GOVX

We tagged GOVX in our extended watchlist on Tuesday, and this stock has made an absolutely eye-popping move.

From its low of .62 on Tuesday, GOVX hit 1.75 yesterday, marking a total two-day upswing of 182% We’ll continue to keep an eye peeled for more activity in this highly volatile play.

Options Ideas:
KMB Weekly $145-148 Calls
DHR 08/21 $200-210 Calls 

Extended Watchlist:
MSTO, WNDW, VYST, TSOI, LTUM

Blue Horseshoe Stocks: MBRX Blows its Lid

 
Kimberly Clark Corp. KMB

We want to kick things off this morning by highlighting the fantastic options idea we included in yesterday morning’s premarket report. That was the KMB Weekly $125-128 Calls, and we’re pleased to relay the stellar first-day performance of those contracts, all four of which produced enormous multibag intraday moves, including a thousand-percent-plus play in the $128’s.

$125 Calls – Range: 1.40-7.14  – Max Gain: 410%
$126 Calls – Range: 1.00-6.50 – Max Gain: 550%
$127 Calls – Range: .72-4.90  – Max Gain: 581%
$128 Calls – Range: .36-4.80  – Max Gain: 1233%
_____

FRESH OPTIONS IDEA:
Twitter, Inc. TWTR Weekly $35.50-37 Calls
Hasbro, Inc. HAS Weekly $97-101 Calls
Lockheed Martin Corp. LMT Weekly $327.50-$337.50 Calls

Moleculin Biotech, Inc. MBRX – Recap

Following the FDA fast-tracking of the company’s Annamycin drug, yesterday morning we noted that this stock we began tracking late last month had risen by 89% (.7772-1.47) right on the heels of the good news. It would appear that the development took some time to fully filter through the investment community, because even we weren’t prepared for the enormous continuation of momentum that has now transpired.

From yesterday’s 1.25 low-of-day, MBRX shot up like a rocket and ultimately reached a new peak of 3.15. That worked out to a single session surge of 152% From our initially observed low, it represents an increase of 305% in just over three weeks of trading. This has not turned out to be our biggest stock-only call of the year so far just yet, but it is right up there among the best.

Extended Watchlist:
TMPS, GNC, AYTU, HLTH, VERB, VTVT, FORK, WVE, RVP, CVM

Blue Horseshoe Stocks: Earnings-Related Options Ideas

OPTIONS REVIEW

We closed out the short week on Thursday with a pair of last minute options ideas, and both of those provided our readers and ourselves with the opportunity to take significant intraday profits.

United Rentals Inc. URI Weekly $134-136 Calls
$134 Calls – Range: 1.65-4.20  – Max Gain: 155%
$135 Calls – Range: .91-3.50 – Max Gain: 285%
$136 Calls – Range: .85-2.73  – Max Gain: 221%

Union Pacific Corp. UNP Weekly $172.50 & 175 Calls
$172.50 Calls – Range: 2.61-5.07  – Max Gain: 94%
$175 Calls – Range: .84-2.95 – Max Gain: 251%

______

EARNINGS RELATED OPTIONS IDEAS
Halliburton Co. HAL Weekly $31.50-32.50 Calls
Kimberly Clark Corp. KMB Weekly $125-128 Calls

Moleculin Biotech, Inc. MBRX – Recap

We highlighted this play at the end of last month, and shortly thereafter we would observe a low of .7772. Last week, MBRX reached a new high of 1.47, which translates to a gain of 89% in roughly three weeks’ time.

The move, which filled the entirety of the topside gap on the chart, was due to Thursday’s revelation that the company’s drug Annamycin had received the FDA’s Approval for fast-track designation. At 4:30PM on Wednesday, MBRX officials will conduct a call to discuss this and other developments on a live webcast, which will be available in the Investor Relations section at www.moleculin.com.

Extended Watchlist:
NBRV, TLGT, FCEL, UXIN, TENX, COMM, KEG, CEI,